Free Fatty Acid Receptor (FFAR)

Free fatty acid receptor (FFAR) ligands act on G protein-coupled receptors (GPCRs) that sense fatty acids. FFAR1 and FFAR4, also called G protein-coupled receptors 40 and 120 (GPR40, GPR120), respond to medium- and long-chain fatty acids. FFAR2 and FFAR3 are GPCRs that instead bind short-chain fatty acids produced by gut bacteria. In 2003 GPR40 was shown to mediate fatty acid-stimulated insulin secretion from pancreatic beta cells. Two years later, GPR120 was linked to fatty acid-induced secretion of glucagon-like peptide 1 (GLP-1) in the gut. Fasiglifam, TUG-770 and LY2922470 are FFAR1 agonists, and GW-1100 is an FFAR1 antagonist. TUG-891 is an FFAR4 agonist, whereas GW9508 acts on both FFAR1 and FFAR4.

Items 51-55 of 55

  • AS2034178 free base
    Cat. No.
    A60375

    AS2034178 free base

    AS2034178 free base is a specific agonist of the Free Fatty Acid Receptor 1 (GPR40). This compound has been demonstrated to enhance glucose-dependent insulin secretion, making it a valuable tool for investigating mechanisms underlying type 2 diabetes mellitus. Its oral bioactivity suggests potential applicability in therapeutic research aimed at metabolic disorders.

    Out of stock

    All 3 sizes
  • FFA1 agonist-1
    Cat. No.
    A60377

    FFA1 agonist-1

    FFA1 agonist-1 is a potent agonist of fatty acid receptor 1 (FFA1), exhibiting an EC50 of 0.75 μM. This compound is designed for research applications related to type 2 diabetes mellitus, where modulation of FFA1 can influence metabolic pathways and insulin sensitivity. FFA1 agonist-1 provides a valuable tool for investigating the therapeutic potential of targeting this receptor in metabolic disorders.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Metabolex-36
    Cat. No.
    A60380

    Metabolex-36

    Synonyms: Met-36

    Metabolex-36 is a potent agonist of the free fatty acid receptor 4 (FFA4), demonstrating a pEC50 value of 5.9. In contrast, it exhibits a significantly lower activity for FFA1, with a pEC50 value of less than 4.0. This compound is crucial for studies focused on metabolic regulation and the modulation of inflammatory pathways, making it a valuable tool in research related to obesity, diabetes, and cardiovascular diseases.

    25 mg
    $1,405.00
    50 mg
    $1,790.00
    All 3 sizes
  • LY2922083
    Cat. No.
    A60384

    LY2922083

    LY2922083 is a potent agonist of the free fatty acid receptor GPR40. This compound activates GPR40 in response to increased blood glucose levels, demonstrating potential as a glucose-lowering agent. Its biological activity makes it a valuable tool for research in metabolic diseases and insulin signaling pathways.

    25 mg
    $1,530.00
    50 mg
    $1,950.00
    All 3 sizes
  • GPR40 Agonist 2
    Cat. No.
    A60385

    GPR40 Agonist 2

    GPR40 Agonist 2 is an agonist of the free fatty acid receptor GPR40, playing a crucial role in glucose metabolism and insulin secretion. This compound is primarily utilized in diabetes research, providing insights into the regulatory mechanisms of energy homeostasis and metabolic disorders. Its activation of GPR40 has potential therapeutic implications for the management of type 2 diabetes and related metabolic diseases.

    25 mg
    $1,655.00
    50 mg
    $2,115.00
    All 3 sizes

Items 51-55 of 55

Added to your cart

View Cart Checkout

    Loading...